Regeneron drugs in demand after Trump coronavirus treatment — but it’s not available to public

Now Trumpoltics gets going to bypass science to boost his income and election chances

1000-24.jpeg?quality=85&strip=all

The company said on Wednesday that it has submitted a request to the U.S. Food and Drug Administration for an emergency use authorization (EUA) for its antibody combination.